Other
Equity method investments (Note 11)
Berkshire Hathaway Equity method investments (Note 11) decreased by 0.1% to $19.95B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 35.9%, from $31.14B to $19.95B. Over 4 years (FY 2021 to FY 2025), Equity method investments (Note 11) shows an upward trend with a 5.6% CAGR.
Analysis
StatementBalance Sheet Statement
SectionOther
First reportedQ4 2021
Last reportedQ1 2026May 4, 2026
Metric ID:
other_equity_method_investmentsHistorical Data
16 periods
| Q4 '21 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $16.05B | $28.71B | $28.05B | $26.4B | $27.49B | $27.5B | $29.07B | $29.59B | $30.07B | $30.13B | $31.13B | $31.14B | $25.32B | $25.52B | $19.98B | $19.95B |
| QoQ Change | — | +79.0% | -2.3% | -5.9% | +4.1% | +0.0% | +5.7% | +1.8% | +1.6% | +0.2% | +3.3% | +0.0% | -18.7% | +0.8% | -21.7% | -0.1% |
| YoY Change | — | — | +74.8% | — | — | -4.2% | +3.6% | +12.1% | +9.4% | +9.6% | +7.1% | +5.3% | -15.8% | -15.3% | -35.8% | -35.9% |
Range$16.05B – $31.14B
CAGR+6.0%
Avg YoY Growth+1.2%
Median YoY Growth+4.4%
Current Streak2 quarters decline
Product Breakdown
| Segment | Q4 '25 |
|---|---|
| Insurance And Other | $19.98B |
| Total | $19.98B |
Equity method investments (Note 11) at Other Companies
Frequently Asked Questions
- What is Berkshire Hathaway's equity method investments (note 11)?
- Berkshire Hathaway (BRK.B) reported equity method investments (note 11) of $19.95B in Q1 2026.
- How has Berkshire Hathaway's equity method investments (note 11) changed year-over-year?
- Berkshire Hathaway's equity method investments (note 11) decreased by 35.9% year-over-year, from $31.14B to $19.95B.
- What is the long-term trend for Berkshire Hathaway's equity method investments (note 11)?
- Over 4 years (2021 to 2025), Berkshire Hathaway's equity method investments (note 11) has grown at a 5.6% compound annual growth rate (CAGR), from $16.05B to $19.98B.